Published in Biomed Res Int on September 20, 2016
Natural Killer Cell (NK-92MI)-Based Therapy for Pulmonary Metastasis of Anaplastic Thyroid Cancer in a Nude Mouse Model. Front Immunol (2017) 0.75
Current Perspectives on In Vivo Noninvasive Tracking of Extracellular Vesicles with Molecular Imaging. Biomed Res Int (2017) 0.75
Molecular Imaging: A Useful Tool for the Development of Natural Killer Cell-Based Immunotherapies. Front Immunol (2017) 0.75
Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol (1986) 35.41
Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36
The dendritic cell system and its role in immunogenicity. Annu Rev Immunol (1991) 23.09
Bone marrow cells regenerate infarcted myocardium. Nature (2001) 21.24
Functions of natural killer cells. Nat Immunol (2008) 9.88
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature (1998) 9.77
Molecular imaging. Radiology (2001) 5.67
T cell activation determined by T cell receptor number and tunable thresholds. Science (1996) 5.51
Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol (1997) 5.21
Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol (2004) 5.07
T cell receptor signaling precedes immunological synapse formation. Science (2002) 4.56
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol (2001) 4.54
B lymphocytes: how they develop and function. Blood (2008) 4.07
Molecular imaging in drug development. Nat Rev Drug Discov (2008) 4.06
Two-photon tissue imaging: seeing the immune system in a fresh light. Nat Rev Immunol (2002) 4.01
Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol (2002) 3.96
Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature (1993) 3.83
Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol (2013) 3.38
Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol Rev (1991) 3.21
Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol (1999) 3.18
Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res (2004) 3.16
Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med (2006) 3.15
Natural-killer cells and dendritic cells: "l'union fait la force". Blood (2005) 3.10
Complement and its role in innate and adaptive immune responses. Cell Res (2009) 3.07
A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur J Nucl Med Mol Imaging (2004) 3.07
Pathogenesis of systemic lupus erythematosus. J Clin Pathol (2003) 2.93
In vivo MRI cell tracking: clinical studies. AJR Am J Roentgenol (2009) 2.85
Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood (2002) 2.79
Design of effective immunotherapy for human autoimmunity. Nature (2005) 2.48
Control of macrophage activation and function by PPARs. Circ Res (2010) 2.34
Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res (2003) 2.32
B cells move to centre stage: novel opportunities for autoimmune disease treatment. Nat Rev Drug Discov (2006) 2.27
Structure and function of immunoglobulins. J Allergy Clin Immunol (2010) 2.22
Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer. Proc Natl Acad Sci U S A (2008) 2.20
Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn Reson Med (2007) 2.18
Tracking immune cells in vivo using magnetic resonance imaging. Nat Rev Immunol (2013) 2.05
Plasma cells: finding new light at the end of B cell development. Nat Immunol (2001) 1.74
Molecular-genetic imaging based on reporter gene expression. J Nucl Med (2008) 1.64
How B cells shape the immune response against Mycobacterium tuberculosis. Eur J Immunol (2009) 1.61
Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu Rev Immunol (2000) 1.59
Activating and inhibitory receptors of natural killer cells. Immunol Cell Biol (2010) 1.58
Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging. Stem Cells (2009) 1.58
Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum Immunol (1999) 1.57
NK cells and cancer. J Immunol (2007) 1.56
To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. J Nucl Med (2004) 1.51
Natural killer cells and interferon. Crit Rev Immunol (1984) 1.49
In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. Eur Radiol (2004) 1.44
MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles. Clin Cancer Res (2011) 1.40
Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. J Immunol (2001) 1.36
Therapeutic targeting of B cells for rheumatic autoimmune diseases. Pharmacol Rev (2011) 1.35
Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18. Cytokine (1999) 1.33
Assessing responses to cancer therapy using molecular imaging. Biochim Biophys Acta (2006) 1.31
Review of functional/anatomical imaging in oncology. Nucl Med Commun (2012) 1.26
Macrophages in gene therapy: cellular delivery vehicles and in vivo targets. J Leukoc Biol (2002) 1.19
Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanoma-expressed self-antigen. Int Immunol (2008) 1.19
Nanoparticles as computed tomography contrast agents: current status and future perspectives. Nanomedicine (Lond) (2012) 1.10
Trial watch: Dendritic cell-based interventions for cancer therapy. Oncoimmunology (2013) 1.09
Evaluation of in vivo labelled dendritic cell migration in cancer patients. J Transl Med (2004) 1.08
In vivo cell tracking with bioluminescence imaging. Nucl Med Mol Imaging (2014) 1.08
Understanding immune cell trafficking patterns via in vivo bioluminescence imaging. J Cell Biochem Suppl (2002) 1.07
Kinetics and organ distribution of allogeneic natural killer lymphocytes transfused into patients suffering from renal cell carcinoma. Stem Cells Dev (2004) 1.04
Optical imaging of cellular immunotherapy against prostate cancer. Mol Imaging (2009) 1.04
Systemic trafficking of macrophages induced by bone cement particles in nude mice. Biomaterials (2008) 1.01
Engineering human tumor-specific cytotoxic T cells to function in a hypoxic environment. Mol Ther (2008) 1.00
Trafficking macrophage migration using reporter gene imaging with human sodium iodide symporter in animal models of inflammation. J Nucl Med (2010) 1.00
In vivo imaging and monitoring of transplanted stem cells: clinical applications. Curr Cardiol Rep (2010) 0.98
Monitoring of a new approach of immunotherapy with allogenic (111)In-labelled NK cells in patients with renal cell carcinoma. Eur J Nucl Med Mol Imaging (2003) 0.96
Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T-Cells in Vivo with Gold Nanoparticles and CT Imaging. ACS Nano (2015) 0.96
An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy. Cancer Res (2015) 0.96
Fluorine-18 labeled mouse bone marrow-derived dendritic cells can be detected in vivo by high resolution projection imaging. J Immunol Methods (2002) 0.95
Noninvasive imaging of dendritic cell migration into lymph nodes using near-infrared fluorescent semiconductor nanocrystals. FASEB J (2008) 0.94
In vivo imaging of immune cell trafficking in cancer. Eur J Nucl Med Mol Imaging (2010) 0.93
Options for tracking GFP-Labeled transplanted myoblasts using in vivo fluorescence imaging: implications for tracking stem cell fate. BMC Biotechnol (2014) 0.92
Molecular imaging of cell-mediated cancer immunotherapy. Trends Biotechnol (2006) 0.92
In vivo migration of labeled autologous natural killer cells to liver metastases in patients with colon carcinoma. J Transl Med (2006) 0.91
MR imaging of in vivo recruitment of iron oxide-labeled macrophages in experimentally induced soft-tissue infection in mice. Radiology (2006) 0.91
Molecular imaging: a new way to study molecular processes in vivo. Mol Cell Endocrinol (2006) 0.91
In vivo tracking of Th1 cells by PET reveals quantitative and temporal distribution and specific homing in lymphatic tissue. J Nucl Med (2014) 0.90
Tracking of [18F]FDG-labeled natural killer cells to HER2/neu-positive tumors. Nucl Med Biol (2008) 0.90
Cancer immunotherapy. Biotechnol J (2006) 0.88
Manufacturing and quality control of cell-based tumor vaccines: a scientific and a regulatory perspective. J Immunother (2006) 0.87
PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments. J Nucl Med (2015) 0.86
Tracking of dendritic cell migration into lymph nodes using molecular imaging with sodium iodide symporter and enhanced firefly luciferase genes. Sci Rep (2015) 0.86
Tracking T-cells in vivo with a new nano-sized MRI contrast agent. Nanomedicine (2012) 0.85
Imaging of activated natural killer cells in mice by positron emission tomography: preferential uptake in tumors. Cancer Res (1993) 0.85
Bioluminescence-based visualization of CD4 T cell dynamics using a T lineage-specific luciferase transgenic model. BMC Immunol (2009) 0.84
In vivo Tracking of Dendritic Cell using MRI Reporter Gene, Ferritin. PLoS One (2015) 0.84
Dual reporter gene imaging for tracking macrophage migration using the human sodium iodide symporter and an enhanced firefly luciferase in a murine inflammation model. Mol Imaging Biol (2013) 0.82
In vivo non invasive molecular imaging for immune cell tracking in small animals. Immune Netw (2012) 0.82
Monitoring the effects of dexamethasone treatment by MRI using in vivo iron oxide nanoparticle-labeled macrophages. Arthritis Res Ther (2014) 0.82
Near-infrared imaging of adoptive immune cell therapy in breast cancer model using cell membrane labeling. PLoS One (2014) 0.82
Implementation of 89Zr production and in vivo imaging of B-cells in mice with 89Zr-labeled anti-B-cell antibodies by small animal PET/CT. Appl Radiat Isot (2011) 0.82
Cancer vaccines based on dendritic cells loaded with tumor-associated antigens. Cell Biol Toxicol (2001) 0.82
In vivo, multimodal imaging of B cell distribution and response to antibody immunotherapy in mice. PLoS One (2010) 0.81
Requisites for successful theranostics with radionuclide-based reporter gene imaging. J Drug Target (2014) 0.79
In Vivo Imaging of Natural Killer Cell Trafficking in Tumors. J Nucl Med (2015) 0.79
Combined Fluorescence and Magnetic Resonance Imaging of Primary Macrophage Migration to Sites of Acute Inflammation Using Near-Infrared Fluorescent Magnetic Nanoparticles. Mol Imaging Biol (2015) 0.78
Superparamagnetic MRI probes for in vivo tracking of dendritic cell migration with a clinical 3 T scanner. Biomaterials (2015) 0.77
Visualization of the Biological Behavior of Tumor-Associated Macrophages in Living Mice with Colon Cancer Using Multimodal Optical Reporter Gene Imaging. Neoplasia (2016) 0.76
Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on 18F-FDG PET/CT in Patients with Papillary Thyroid Carcinoma. PLoS One (2015) 0.78
Role of pulmonary macrophages in initiation of lung metastasis in anaplastic thyroid cancer. Int J Cancer (2016) 0.76
In Vivo Tracking of Chemokine Receptor CXCR4-Engineered Mesenchymal Stem Cell Migration by Optical Molecular Imaging. Stem Cells Int (2017) 0.75